CDMO PROFILE
PharmaCorp Manufacturing Solutions
Global leader in pharmaceutical development and manufacturing services
|
|
45+
Years in Industry
5
Global Facilities
600+
Regulatory Filings
EXCLUSIVE INTERVIEW
An Exclusive Conversation with Dr. James Mitchell
Where do you see the industry heading in the next decade?
Personalized medicine will fundamentally reshape manufacturing. We’ll see smaller batch sizes, more complex supply chains, and greater demand for flexibility. CDMOs that can offer platform technologies for rapid product changeover while maintaining quality and compliance will thrive. Sustainability will also become a key differentiator.
Where do you see the industry heading in the next decade?
Personalized medicine will fundamentally reshape manufacturing. We’ll see smaller batch sizes, more complex supply chains, and greater demand for flexibility. CDMOs that can offer platform technologies for rapid product changeover while maintaining quality and compliance will thrive. Sustainability will also become a key differentiator.
Where do you see the industry heading in the next decade?
Personalized medicine will fundamentally reshape manufacturing. We’ll see smaller batch sizes, more complex supply chains, and greater demand for flexibility. CDMOs that can offer platform technologies for rapid product changeover while maintaining quality and compliance will thrive. Sustainability will also become a key differentiator.
Where do you see the industry heading in the next decade?
Personalized medicine will fundamentally reshape manufacturing. We’ll see smaller batch sizes, more complex supply chains, and greater demand for flexibility. CDMOs that can offer platform technologies for rapid product changeover while maintaining quality and compliance will thrive. Sustainability will also become a key differentiator.
Dr. James Mitchell
Founder & Chief Executive Officer
Dr. Mitchell founded PharmaCorp in 1974 with a vision to transform pharmaceutical manufacturing. With over 40 years of industry experience, including leadership roles at major pharmaceutical companies, he has pioneered innovations in continuous manufacturing and biologics processing.
About
PharmaCorp Manufacturing Solutions stands as one of the world’s most comprehensive contract development and manufacturing organizations. With over 45 years of pharmaceutical expertise, we offer fully integrated, end-to-end solutions spanning drug substance and drug product development through commercial manufacturing at scale.
What Makes Them Unique?
True end-to-end integrated services from drug substance through commercial manufacturing
Global manufacturing footprint with facilities on 4 continents
Strong financial stability and long-term investment commitment
Comprehensive technology portfolio spanning small molecules, biologics, and cell/gene therapy
Virtual Facility Tour
Take an exclusive inside look at state-of-the-art manufacturing facilities and quality control laboratories.
Plans for the Future
2025 EXPANSION
New Biologics Campus
$500M investment in next-generation biologics manufacturing facility with 40,000L capacity.
TECHNOLOGY
Continuous Manufacturing
Industry 4.0 integration with AI-powered process optimization across all facilities
Frequently Asked Questions
Our integrated approach typically reduces time-to-market by 20-30% compared to multi-vendor strategies. For small molecules, expect 18-24 months from development through commercial validation. Biologics programs typically run 24-36 months.
We offer flexible manufacturing scales to accommodate companies of all sizes. For oral solid dose, we can start from 10kg development batches up to multi-ton commercial campaigns.
Yes, we offer both shared and dedicated suite options depending on program requirements. Dedicated suites are recommended for products with complex containment needs.
Our regulatory affairs team includes 200+ professionals supporting global submissions. We provide comprehensive support including CMC documentation, IND/NDA/BLA filings, and EU/international dossiers.
IP protection is paramount. We maintain strict confidentiality protocols, segregated production areas, controlled access to documentation, and robust IT security.
Schedule a Meeting
Connect with our technical experts to discuss your development and manufacturing requirements.
Book Appointment →Company Brochure
Download our comprehensive capabilities brochure and facility overview.
Download BrochureUpcoming
Partnering with PharmaCorp
Ready to Partner?
Contact our team to discuss your project requirements and discover how we can accelerate your path to market.
What PharmaCorp Partners Say
PharmaCorp has been instrumental in bringing our flagship oncology drug to market. Their expertise in complex formulations and unwavering commitment to quality exceeded our expectations.
Dr. Sarah Chen
VP of Manufacturing
Leading BioTech Company
The seamless technology transfer and their proactive communication throughout the process made a potentially complex project straightforward. They truly understand partnership.
Dr. Sarah Chen
VP of Manufacturing
Leading Biotech Company
Their cell and gene therapy capabilities are world-class. We've been working together for 5 years and they continue to innovate alongside us.
Dr. Sarah Chen
VP of Manufacturing
Leading Biotech Company
Latest Tips
- 5 Ways to Optimize Cold Chain Efficiency
- Understanding FDA’s New Guidance on AI
- Best Practices for CDMO Selection
Latest Q&A
- What’s driving biologics outsourcing growth?
- How are CDMOs adapting to GLP-1 demand?
- Will AI replace quality control roles?
